IRIS Institutional Research Information System - OPENBS Open Archive UniBS

METRA, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 88.738
AS - Asia 58.596
EU - Europa 46.752
SA - Sud America 12.421
AF - Africa 1.336
OC - Oceania 126
Continente sconosciuto - Info sul continente non disponibili 90
AN - Antartide 2
Totale 208.061
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 87.035
SG - Singapore 19.434
CN - Cina 19.080
UA - Ucraina 10.949
BR - Brasile 10.447
IT - Italia 7.818
HK - Hong Kong 7.782
RU - Federazione Russa 5.407
DE - Germania 5.193
PL - Polonia 3.683
FR - Francia 3.616
VN - Vietnam 3.439
FI - Finlandia 3.072
GB - Regno Unito 2.611
TR - Turchia 2.354
IN - India 2.130
IE - Irlanda 1.968
BD - Bangladesh 1.442
CA - Canada 770
AR - Argentina 745
SE - Svezia 714
MX - Messico 540
IQ - Iraq 491
NL - Olanda 373
ID - Indonesia 366
ZA - Sudafrica 358
EC - Ecuador 325
JP - Giappone 285
SA - Arabia Saudita 262
AT - Austria 255
PK - Pakistan 248
ES - Italia 221
CO - Colombia 220
VE - Venezuela 179
MA - Marocco 172
NG - Nigeria 164
UZ - Uzbekistan 155
KE - Kenya 151
PY - Paraguay 151
CL - Cile 135
CZ - Repubblica Ceca 134
BE - Belgio 130
QA - Qatar 119
AU - Australia 114
EG - Egitto 105
TN - Tunisia 103
AE - Emirati Arabi Uniti 91
PE - Perù 90
MU - Mauritius 86
JO - Giordania 85
UY - Uruguay 81
NP - Nepal 79
PH - Filippine 78
EU - Europa 76
JM - Giamaica 75
IL - Israele 70
MY - Malesia 64
RO - Romania 63
LT - Lituania 60
AZ - Azerbaigian 54
IR - Iran 54
KR - Corea 54
CH - Svizzera 53
HN - Honduras 53
DZ - Algeria 50
KZ - Kazakistan 50
PA - Panama 48
TT - Trinidad e Tobago 48
EE - Estonia 47
ET - Etiopia 47
AL - Albania 45
OM - Oman 42
DO - Repubblica Dominicana 41
MD - Moldavia 39
BO - Bolivia 37
LB - Libano 36
TH - Thailandia 36
TW - Taiwan 35
PT - Portogallo 33
BG - Bulgaria 32
NO - Norvegia 32
CR - Costa Rica 30
PS - Palestinian Territory 29
SN - Senegal 28
HU - Ungheria 27
GR - Grecia 26
LV - Lettonia 25
BH - Bahrain 22
KG - Kirghizistan 22
RS - Serbia 21
SC - Seychelles 20
NI - Nicaragua 19
SK - Slovacchia (Repubblica Slovacca) 19
SV - El Salvador 18
SY - Repubblica araba siriana 18
DK - Danimarca 15
MK - Macedonia 15
GT - Guatemala 13
XK - ???statistics.table.value.countryCode.XK??? 13
BA - Bosnia-Erzegovina 12
Totale 207.801
Salva come PNG Salva come JPEG
Città #
Singapore 10.002
Fairfield 8.129
Jacksonville 8.009
Hong Kong 7.745
Ashburn 7.040
Woodbridge 6.026
Houston 4.220
Chandler 4.080
Moscow 4.056
The Dalles 3.763
Beijing 3.740
San Jose 3.623
Warsaw 3.611
Cambridge 3.591
Princeton 3.515
Wilmington 3.440
Ann Arbor 3.254
Seattle 3.122
Nanjing 2.769
New York 2.332
Dublin 1.949
Lauterbourg 1.883
Istanbul 1.842
Los Angeles 1.575
Helsinki 1.505
Ho Chi Minh City 1.221
Nanchang 1.039
Buffalo 974
Milan 973
São Paulo 872
Des Moines 826
Shenyang 684
Hanoi 669
Hebei 661
Redondo Beach 626
Changsha 615
Dallas 579
Tianjin 544
Munich 526
San Diego 515
Council Bluffs 475
Brescia 472
Jiaxing 458
Rome 420
Shanghai 420
Chicago 411
Jinan 411
Dearborn 377
Orem 356
Santa Clara 356
London 344
San Francisco 344
Rio de Janeiro 340
Hangzhou 327
Boardman 326
Kunming 322
Frankfurt am Main 299
Kocaeli 247
Tokyo 245
Verona 244
Nuremberg 243
Chennai 241
Belo Horizonte 235
Guangzhou 222
Romola 221
Brooklyn 216
Toronto 214
Mexico City 199
Zhengzhou 197
Montreal 184
Atlanta 182
Brasília 172
Turku 171
Lancaster 164
Curitiba 158
Johannesburg 158
Lappeenranta 148
Pune 148
Abuja 146
Dhaka 145
Phoenix 145
Ningbo 140
Tashkent 140
Porto Alegre 138
Boston 136
Lanzhou 134
Baghdad 132
Haiphong 132
Denver 131
Da Nang 130
Manchester 130
Salvador 126
Nairobi 125
Stockholm 121
Dong Ket 120
Doha 119
Charlotte 118
Brussels 113
Campinas 113
Amsterdam 112
Totale 129.658
Salva come PNG Salva come JPEG
Nome #
Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: A multiparametric approach to heart failure prognosis 3.376
Un caso di Sindrome di Bland-White-Garland: origine anomala dell’arteria coronaria sinistra dall’arteria polmonare. 728
Effect of nesiritide in patients with acute decompensated heart failure. 523
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 478
American College of Cardiology; American Heart Association Task Force; European Society of Cardiology Committee for Practice Guidelines. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). 421
Inodilatatori: perché e quali. 408
Farmaci inotropi non digitalici. 387
La cardiomioplastica dinamica come trattamento della cardiomiopatia dilatativa ingravescente. 371
Livelli circolanti del marcatore tumorale CA 125 in pazienti con scompenso cardiaco cronico:relazione con la classe NYHA, i parametri ecocardiografici e variazioni indotte dalla terapia. 368
Il genotipo DD per il gene dell’enzima di conversione dell’angiotensina identifica i pazienti con insufficienza cardiaca che possono beneficiare di dosi medio elevate di ACE inibitori. 341
Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes. 341
Worsening renal function in patients hospitalised for acute heart failure: Clinical implications and prognostic significance 338
Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European society of cardiology and endorsed by the European society of intensive care medicine 335
Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial 317
Can we improve the treatment of congestion in heart failure? 305
Impact of serial troponin release on outcomes in patients with acute heart failure: Analysis from the protect pilot study 291
The predictive value of short-term changes in hemoglobin concentration in patients presenting with acute decompensated heart failure 290
Acute heart failure: multiple clinical profiles and mechanisms require tailored therapy. 288
Effects of the long-term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: results of the ELANDD study. 280
Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function. 280
Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure 265
Role of beta1- and alpha2c-adrenergic receptor polymorphisms and their combination in heart failure: a case-control study 259
Hemodynamic Predictors of Heart Failure Morbidity and Mortality: Fluid or Flow? 259
Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. 258
Old and new intravenous inotropic agents in the treatment of advanced heart failure 258
Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance. 258
I polimorfismi Arg16Gly del gene recettore beta-2 adrenergico influenzano i parametri emodinamici e la prognosi dei pazienti con insufficienza cardiaca 257
Should beta-blocker therapy be reduced or withdrawn after an episode of decompensated heart failure? Results from COMET. 250
Troponin T levels in patients with acute heart failure : clinical and prognostic significance of their delection and release during hospitalisation 247
May 2020 at a glance: ischaemic heart failure and sex-related differences 240
Troponin I in acute decompensated heart failure: insights from the ASCEND-HF study 239
L’ indice di performance miocardica ( MPI ) è un importante indicatore prognostico nei pazienti affetti da insufficienza cardiaca cronica. 238
Postdischarge assessment after a heart failure hospitalization: the next step forward. 234
I polimorfismi Arg16 Gly del gene recettore beta-2 adrenergico influenzano i parametri emodinamici e la prognosi dei pazienti con insufficienza cardiaca. 233
Highlights of the 2009 scientific sessions of the European Society of Cardiology. 226
Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial. 225
Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT Study 223
Nebivolol: haemodynamic effects and clinical significance of combined beta-blockade and nitric oxide release. 221
Beta-blocker treatment of patients with diastolic heart failure and arterial hypertension. A prospective, randomized, comparison of the long-term effects of atenolol vs. nebivolol. 217
Effects of serelaxin in patients with acute heart failure 214
Early drop in systolic blood pressure and worsening renal function in acute heart failure: renal results of Pre-RELAX-AHF. 213
Sindromi coronariche acute: ruolo dell’infezione cronica da Helicobacter Pylori e Citomegalovirus. 212
Characteristics and mid-term follow-up of a single-center population affected by Tako-Tsubo cardiomyopathy 209
Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: A long-term comparison 208
Use of inotropic agents in patients with advanced heart failure: lessons from recent trials and hopes for new agents. 206
Advanced chronic heart failure: A position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Societyof Cardiology 204
Effects of the Adenosine A(1) Receptor Antagonist Rolofylline on Renal Function in Patients With Acute Heart Failure an Renal Dysfunction Results From PROTECT (Placebo-Controlled Randomized Study of the Selective A(1) Adenosine ReceptorAntagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function) 204
Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry 201
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy 200
Percutaneous edge-to-edge mitral valve repair for the treatment of acute mitral regurgitation complicating myocardial infarction: A single centre experience 199
Task Force sullo Scompenso Cardiaco Acuto della Societa Europea di Cardiologia. Versione italiana a cura di A Gavazzi, M Metra. Riassunto esecutivo delle linee guida sulla diagnosi e trattamento dello scompenso cardiaco acuto. 196
Prognosis and NT-proBNP in heart failure patients with preserved versus reduced ejection fraction 196
Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials. 194
Left ventricular reverse remodelling predicts long-term outcomes in patients with functional mitral regurgitation undergoing MitraClip therapy: results from a multicentre registry 194
Efficacia di un nuovo diuretico, la muzolimina, in pazienti con insufficienza cardiaca. 193
Fattori di rischio ed “epidemiologia inversa” nei pazienti con insufficienza cardiaca. 193
A randomized double-blind crossover study of nicardipine and nifedipine in patients with angina pectoris and concomitant essential hypertension. 193
Mitraclip therapy in patients with functional mitral regurgitation and missing leaflet coaptation: is it still an exclusion criterion? 193
The role of n-3 PUFAs in preventing the arrhythmic risk in patients with idiopathic dilated cardiomyopathy. 191
Determinazione dell’equilibrio simpato-vagale attraverso l’analisi spettrale della variabilità della frequenza cardiaca in pazienti con insufficienza cardiaca di diverso grado di severità. 190
Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy 188
Acute and chronic effects of the dihydropyridine calcium antagonist nisoldipine on the resting and exercise hemodynamics, neurohumoral parameters, and functional capacity of patients with chronic heart failure. 187
A case of iatrogenic severe mitral regurgitation 186
Self-expanding transcatheter aortic valve implantation for degenerated small Mitroflow bioprosthesis: Early and midterm outcomes 186
Global epidemiology of heart failure 185
Adrenergic receptor gene polymorphism and left ventricular reverse remodelling after cardiac resynchronization therapy: preliminary results 185
Amino acids and derivatives, a new treatment of chronic heart failure? 185
Effetti cardiovascolari della ventilazione servo-adattativa (ASV) in pazienti affetti da apnee notturne e scompenso cardiaco cronico con disfunzione sistolica ventricolare sinistra 184
Effectiveness of MitraClip therapy in patients with refractory heart failure 182
A drastic complex atheromatous aorta. A case report. 180
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events. 180
Clinical trials update from the World Congress of Cardiology 2006. 179
Systemic lupus erythematosus and endothelial dysfunction: A close relationship 177
Can we prevent or treat renal dysfunction in acute heart failure? 176
An unusual case of myocardial infarction 175
Effects of ivabradine on endothelial function, aortic properties and ventricular-arterial coupling in chronic systolic heart failure patients 175
Are Beta-1 and alpha2c-adrenergic receptor polymorphisms associated with an increased risk of heart failure in Caucasian subjects: results of a case-control study 173
Agents with vasodilator properties in acute heart failure: how to design successful trials 173
Clinical Presentation and Outcome in a Contemporary Cohort of Patients with Acute Myocarditis: The Multicenter Lombardy Registry 173
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry 173
Neurohormonal activation in acute heart failure: results from VERITAS 172
ESC Committe for Practice Guideline (CPG). Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. 172
A rationale for the use of BETA-blockers as standard treatment for heart failure 171
January 2017 at a glance: oncology, diabetes and antidiabetic treatment, pulmonary hypertension 171
Acute hemodynamic effects of the two dopaminergic agonists ibopamine and dihydroergotamine, a comparison with the parent compound. 170
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 169
Beta- adrenergic receptors polymorphisms and response to CRT 168
Mineralocorticoid receptor antagonists for heart failure: a real-life observational study 167
2024 update in heart failure 164
Effect of High dose of atorvastatin versus moderate dose on endothelial function and inflammatory biomarkers in patients with STEMI 164
EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot) 164
Heart failure in elderly patients: distinctive features and unresolved issues 163
1Beta-2 adrenergic receptors gene polymorphisms influence the effects of carvedilol in the patients with heart failure. 162
Hyponatremia and long-term outcomes in chronic heart failure--an observational study from the Duke Databank for Cardiovascular Diseases. 162
Different types of tricuspid flail: Case reports and review of the literature 162
Raised homocystein plasma concentration in patients with heart failure: Clinical significance 161
High-dose atorvastatin versus moderate dose on early vascular protection after ST-elevation myocardial infarction 161
EkoSonic Endovascular System for patients with acute pulmonary embolism and contraindication to systemic fibrinolysis 161
The role of plasma biomarkers in acute heart failure. Serial changes and independent prognostic value of NT-proBNP and cardiac troponin-T 160
Is there a rationale for antiplatelet therapy in acute heart failure? 160
Totale 26.182
Salva come PNG Salva come JPEG
Categoria #
all - tutte 1.094.964
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.094.964
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021715 0 0 0 0 0 0 0 0 0 0 0 715
2021/202211.528 453 2.281 230 766 247 621 378 981 646 1.315 1.114 2.496
2022/202312.157 1.997 251 132 995 1.079 3.563 47 1.195 1.745 107 505 541
2023/202412.855 752 279 742 837 523 1.817 460 472 3.495 340 741 2.397
2024/202533.663 983 971 811 3.719 3.830 2.485 2.772 1.475 2.820 2.920 6.446 4.431
2025/202663.543 5.959 9.470 5.066 9.586 4.792 3.839 8.793 2.945 4.027 5.462 2.489 1.115
Totale 210.040